Command Palette

Search for a command to run...

Tier IIIBehavioural · heat shock142 trials

Sauna (Finnish) — Heat Shock Therapy

Finnish sauna is a traditional heat therapy involving short exposures to high temperatures (80–100°C) in a dry environment. Regular sauna use is strongly associated with reduced cardiovascular and all-cause mortality, likely through mechanisms mimicking moderate-to-vigorous aerobic exercise and the induction of heat shock proteins.

Not yet available in retail — research compound only

Mechanism of Action

Heat exposure induces cardiovascular stress, increasing heart rate, cardiac output, and skin blood flow, which improves endothelial function and arterial compliance. At the cellular level, thermal stress activates heat shock factor 1 (HSF1), leading to the upregulation of heat shock proteins (HSPs) such as HSP70. These chaperones prevent protein aggregation, assist in protein folding, and reduce oxidative stress and inflammation. The physiological response closely mimics the cardiovascular and metabolic adaptations seen with moderate aerobic exercise.

Human Trial Evidence

Large prospective cohort studies in Finland have demonstrated a dose-dependent reduction in mortality risk. A landmark 2015 study in JAMA Internal Medicine following over 2,300 men found that using a sauna 4–7 times per week was associated with a 40% reduction in all-cause mortality and a 50% reduction in fatal cardiovascular events compared to once-weekly use.

Dosing Protocol

Traditional Finnish sauna protocols involve temperatures of 80–100°C (176–212°F) with low humidity (10–20%). Optimal longevity benefits are associated with 4–7 sessions per week, with each session lasting 15–20 minutes or more. Hydration before and after is essential.

Safety & Contraindications

Generally safe for healthy individuals and those with stable cardiovascular disease. Contraindicated in unstable angina, recent myocardial infarction, severe aortic stenosis, and decompensated heart failure. Alcohol consumption during sauna use significantly increases the risk of hypotension, arrhythmias, and sudden death.

Quick Stats
Evidence TierTier III
Clinical Trials142
Typical Dose20 min × 4
Est. Cost/Day
Purity
Synergistic Compounds
Cold ThermogenesisZone-2 CardioResistance Training
Medical disclaimer: This page is for informational purposes only. Consult a qualified healthcare provider before starting any supplement regimen. Vitaei does not provide medical advice.